You have no items in your shopping cart.
GSK-3β inhibitor 14
SKU: orb1685555
Description
Research Area
Pharmacology & Drug Discovery, Signal Transduction, Stem Cell & Developmental Biology
Images & Validation
−
Key Properties
−| CAS Number | 863004-48-2 |
|---|---|
| MW | 283.39 |
| Purity | 99.97% (May vary between batches) |
| Formula | C17H17NOS |
| SMILES | C(N1C=2C(SC(C)CC1=O)=CC=CC2)C3=CC=CC=C3 |
| Target | GSK-3 |
| Solubility | DMSO:2.88 mg/mL (10.16 mM) |
Bioactivity
−| Target IC50 |
|---|
Storage & Handling
−| Storage | -20°C |
|---|---|
| Expiration Date | 12 months from date of receipt. |
| Disclaimer | For research use only |
Alternative Names
−1,5-Benzothiazepin-4(5H)-one, 2,3-dihydro-2-methyl-5-(phenylmethyl)-, GSK-3β inhibitor 14, GSK-3β, GSK-3beta inhibitor 14, GSK-3b inhibitor 14, GSK3
Similar Products
−TCS 21311 [orb1307693]
99.39% (May vary between batches)
1260181-14-3
526.51
C27H25F3N4O4
10 mg, 5 mg, 1 ml x 10 mM (in DMSO), 25 mg, 1 mgLaduviglusib trihydrochloride [orb1704618]
99.34% (May vary between batches)
1782235-14-6
573.71
C22H20Cl5N8
1 mg, 5 mg, 10 mg, 25 mg, 50 mg, 100 mg, 1 ml x 10 mM (in DMSO)CDK8-IN-12 [orb1745164]
99.83% (May vary between batches)
2613307-67-6
381.86
C21H20ClN3O2
1 mg, 5 mg, 10 mg, 25 mg, 50 mg, 100 mg, 1 ml x 10 mM (in DMSO), 200 mgRGB-286638 free base [orb1223052]
>98% (HPLC)
784210-88-4
545.63
C29H35N7O4
2 mg, 5 mg, 10 mg, 25 mg, 50 mg, 100 mg, 200 mg, 500 mg, 1 g
Quality Guarantee
Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at [email protected].
Compound Identifiers
PubChem CID
Key Properties
− No computed properties available.
Protocol Information
Available Sizes
Select a size below
Usually dispatched within 5-10 working days